Founder & CEO
ID Capital Pte. Ltd.
Isabelle set up ID Capital in 2012 when moving to Singapore after a 20-year corporate career in the luxury industry, her last position being SVP Marketing & Communications for the Cognac brand Hennessy. After looking at several emerging sectors to invest in she realized the FoodTech & AgriTech sectors were bound for dramatic change. Future Food Asia was born mid 2016 out of the belief that challenges facing agriculture are often region-specific, and thus, the best minds to tackle these problems can be found within local teams. It aims at fostering innovation in food sustainability and multiplying investment opportunities across Asia Pacific. Today Future Food Asia is in its third year and ID Capital is has been appointed as a co-investment partner in agrifoodtech startups by SEEDS Capital, the investment arm of Enterprise Singapore. Along with her team, Isabelle scouts and reviews a few hundred agrifoodtech startups every year.
Dr. Ralph GRAICHEN
Senior Director, Food and Consumer Biomedical / Science & Engineering Research Council
Dr Ralph Graichen is currently Senior Director, Food & Consumer at the Agency for Science, Technology and Research (A*STAR), Singapore. He has a co-appointment as Adjunct Associate Professor with Nanyang Technological University, School of Chemical & Biomedical Engineering. In his current position with A*STAR, Ralph is working with strategic partners to administer and develop new initiatives and programmes in the research areas of food, nutrition and consumer care, e.g. the Singapore Food Story, a $144 million program to carry out R&D in Sustainable Urban Food Production, Future Foods and Food Safety Science & Innovation. Ralph is a board member of the Singapore Food Agency as well as a member of the Singapore Food Standard Committee. He is also advising multiple start-ups in the food space. Ralph has over 15 years of experience in the local and global biomedical and nutrition industry. He was previously Research Operations Manager for Abbott Nutrition in Asia, establishing the R&D infrastructure and managing the research portfolio for Asia. Prior to joining AN, Ralph was Research Director for ES Cell International, the first organization to provide clinical grade embryonic stem cell lines to the world’s research community (now a subsidiary of Bio Time Inc). Preceding ES Cell Ralph was part of the regional business development team at Roche Diagnostics Asia Pacific. Ralph graduated with a master in Biology from the Johannes Gutenberg University, Mainz, Germany and attained his PhD from the National University Singapore through the Institute of Molecular and Cell Biology. Ralph attended the Food System Leadership Institute, a program of the Association of Public and Land-Grant Universities (APLU) with support from the W.K. Kellogg Foundation.
President of Greater China
Corteva Agriscience™ Agriculture
Division of DowDupont
Mr. Peter Huang is the president of Greater China, Corteva Agrisciecne™, agriculture division of DowDupont. He has been leading the Greater China operation of the agriculture division since the Dow-Dupont merger. In this position, Peter is responsible for the integration of the heritage Dow AgroSciences, Dupont Crop Protection and Pioneer Seeds businesses and setting up a stand-alone company for Corteva Agriscience in Greater China. Mr. Huang joined DuPont in 2004, as a senior business analyst for fluorine product business unit in its headquarter in Wilmington, Delaware. In 2005, he relocated to Asia and served on a variety of roles in AP including six-sigma black belt, master black-belt, regional marketing manager and China business manager. In 2009, Peter joined DuPont Building Innovations as the director of Greater China and later on was appointed as the director of Asia Pacific. In 2014, Mr. Huang joined DuPont Crop Protection business and started his journey in the agriculture industry. Mr. Huang also serves as the Chairman of Crop Life China, an international federation representing the plant science industry in China. Before joining DuPont, Peter was a management consultant in A.T.Kearney, providing management consultancy, such as business strategy development, corporate governance, market entry plan, organization restructure, for MNCs, SOEs and private companies from various industries. Peter Huang holds bachelor degree from Donghua University, master degree from Fudan University and MBA from The Wharton School, University of Pennsylvania.
Former Director of Partnerships, Transfer and Innovation
Director of Partnerships, Transfer and Innovation at INRA, Europe’s top agricultural research institute and the world’s number two centre for the agricultural sciences. Former President of Technology Transfer subsidiaries at INRA, Former President of Quae Editions, a publishing house specialized in scientific and technological content. A trained engineer, Gérard Jacquin graduated from Ecole Polytechnique in France in 1973. In 1978 he became Engineer General of Water and Forestry Engineering (ENGREF Institute), under the authority of the Ministry of Agriculture. Between 1982 and 1992 he held various operational positions in the domain of biotechnologies applied to diagnostic and treatment, and Plasma Protein Fractionation. In 1992 he was appointed MD for the Biology Division of Groupe Générale de Santé, the 1st French group of private hospitals and clinics. From 1994 to 2001 he worked for the National Research Institute of Science and Technology for Environment and Agriculture (IRSTEA), ultimately as the Director for Development and Innovation. From 2001 to 2207 he ran the MIS division of INRA, then became Director of Partnerships, Transfer and Innovation. Over that period of time Gérard has also had a number of board positions. Along with VC firm Seventure he created the first agro-biotech accelerator that became Enterome, a startup pioneering the metagenomics of the digestive tract and its applications in human health. Upon leaving INRA in 2016 Gérard has been leveraging his domain experience to assess innovative projects and mentor talented teams in the sector of agriculture, alimentation and environment.
Dr. Mark Lyons
President & CEO
Dr. Mark Lyons grew up in the Alltech business, having traveled with his father and Alltech’s founder, Dr. Pearse Lyons, from a young age to visit customers. With experience working in all regions and nearly all departments — from palletizing bags in production to researching in the lab — he has a deep and uniquely personal knowledge of the company.Based on Alltech’s belief that agriculture has the greatest potential to shape our world’s future, he launched the Planet of Plenty™ vision in 2019. He has called for collaboration to improve nutrition, human and animal well-being, and the preservation of natural resources.He has spearheaded many critical projects, including simultaneously managing a biorefinery project in Kentucky, the establishment of a plant in Serbia and the creation of Alltech’s flagship yeast production facility in São Pedro, Brazil. He also spent nearly four years in Mexico rebuilding the company’s solid state fermentation plant in Serdan, which is one of the largest of its kind in the world. In 2012, Dr. Lyons relocated to China, the world’s largest feed market, as part of Alltech’s focus on the Asia- Pacific region. Living in Beijing and traveling throughout the country, he led the Alltech China office and focused on building bridges between China and the wider industry through research, education and strategic initiatives. Under his leadership as director of North America from 2009 to 2011, Alltech expanded its presence with the opening of new offices and a growing involvement in all agricultural sectors. Today, Dr. Lyons is based at Alltech’s headquarters in Kentucky. He has served as a board member of the American Feed Industry Association, and he is currently serving on the board of directors for Transylvania University and the advisory board for Women in Food & Agriculture. Dr. Lyons is active in many industry groups, such as the International Poultry Council, the National Turkey Federation, the National Chicken Council and the National Pork Producers Council. He is also vice president of the Soil and Fertilizer Alliance of China and is a committee member of the China Toxicology Association. He is proud to be the only foreign member welcomed to China’s Feed Industry Golf Group, which represents more feed tonnage than all of Brazil. Dr. Lyons has published papers and patents in areas ranging from enzyme production to global economics and is interested in the assurance of food safety and quality throughout the entire food chain. He was also named as one of “The top 50 Irish business men and women in the BRIC countries” and “40 Under 40” leaders in agriculture by Vance Publishing Corporation. He received his bachelor’s degree in political science and environmental science in 1999 from the University of Chicago. He received his master’s degree in brewing and distilling in 2001, followed by a Ph.D. in the area of solid state fermentation, at Heriot-Watt University in Edinburgh. Dr. Lyons is fluent in Spanish, Portuguese, French and German, and he has a working knowledge of Mandarin.
Dr. Yukihiro Maru
Founder & CEO
Leave a Nest Co., Ltd.
Dr. Maru is the founder and CEO of Leave a Nest Group. He earned a Doctorate degree at the Graduate School of Agriculture and Life Sciences, the University of Tokyo. He founded Leave a Nest Co., Ltd. in 2002, which became a leading science bridge communication company in Japan. Dr. Maru is the technical advisor for euglena Co., Ltd. which was listed in the First Section of the Tokyo Stock Exchange in 2014. He is also an innovator who has been involved in launching more than 78 startups including Challenergy, Inc. At the same time, he is holding the role as co-founder of Real Tech Fund and science evangelist of Drone Fund. He is an expert in advising young entrepreneurs in business development and venture spirit.
North Summit Capital
Dr. Wanli Min received PhD in Statistics from the University of Chicago in 2004 and subsequently held research positions at IBM T. J. Watson Research Center, IBM Singapore, Google and Chief Machine Intelligence Scientist at Alibaba Cloud. His research areas include probability theory, stochastic process, time series and machine learning. He was named by Forbes as one of ‘China’s AI Leader’ and was appointed by the Ministry of Science & Technology, People’s Republic of China as an Advisor on the National Committee of Next-generation AI Strategy. In 2019, he launched North Summit Capital, an investment fund focusing on digital transformation in agriculture, healthcare and manufacturing sectors. NSC takes tech+capital approach toward value creation and value capture in evergreen industries.
Brian Sheng is the Founder and CEO of Asia Horizon, a private equity investment and operating company focused on the emerging legal hemp and cannabis industry in Asia. Prior to founding Asia Horizon, Brian was a General Partner at The Arcview Group, the largest cannabis focused investment group in the US. At Arcview, Brian served as the Chief Investment Officer and led the firm’s global investment and hemp strategies. Before joining the hemp industry, Brian was an early stage technology venture capital investor. Brian was the founder of Fresh VC, where he focused on frontier technology categories such as water, new healthcare, and government data. Brian led early investments in companies such as include Eaze, FND Technology, Anderson Leonard Pharmaceuticals, FiscalNote, and Clever Leaves (f.k.a Northern Swan). Brian graduated from Princeton University.
Dao Foods International
Albert is co-founder of Dao Foods International which is a cross-border impact venture established to help talented entrepreneurs introduce exciting new plant-based meat and alternative protein products in China. With rapidly rising incomes and increasing meat consumption in China, our aim is to introduce alternative products into the China market to reduce the consumer demand for animal products which has had growing negative climate, environmental, food safety and health impact. Over his career, Albert has managed a portfolio of impact investments, been COO of a venture backed social enterprise, has consulted to United Nations on social business models, has worked in Africa on HIV health system efficiency, and has worked in business development for a major multinational as a biomedical engineer. Albert has a MPA from Harvard Kennedy School, a MHSc. in Biomedical Engineering from the University of Toronto, and a BASc. in Mechanical Engineering from the University of Waterloo.